Will Morton

Nuclear Medicine
Kidneys appear to tolerate Lu-177 treatments
Kidney-absorbed doses of lutetium-177 (Lu-177)-based treatments for prostate cancer and neuroendocrine tumors appear to be below toxicity thresholds.
December 19, 2024
Kidneys
Molecular Imaging
AuntMinnie.com Molecular Imaging Insider
RSNA 2024 wrapped up in Chicago recently, with theranostics taking center stage. Click "Read More" to learn about one more study from the meeting – findings that suggest African Americans respond more favorably to Ra-223 treatment – and other news.
December 17, 2024
Molecular Imaging
African American men respond more favorably to Ra-223 therapy
African American men with metastatic castrate-resistant prostate cancer may respond more favorably than white men to treatment with radium-223.
December 17, 2024
Prostate Imaging
Molecular Imaging
PET visualizes acute graft vs. host disease
F-18 fluorothymidine PET can identify early acute gastrointestinal graft versus host disease after patients undergo bone marrow transplants.
December 16, 2024
F-18 FLT-PET imaging of gastrointestinal GVHD. Examples of F-18 FLT uptake in a participant with no GVHD (left) and a participant with acute GVHD and uptake in the jejunum and ileum (right). Arrows denote increased uptake in the GI tract. Image available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of RSNA.
Interventional
Minimally invasive spine surgeries reduce long-term opioid use
Minimally invasive image-guided procedures to treat osteoporotic vertebral fractures appear to be effective for decreasing long-term use of pain medication.
December 13, 2024
Spine Pain
Molecular Imaging
Immuno-PET tracer shows promise in patients with liver cancer
A new PET radiotracer has the potential for visualizing responses in liver cancer patients undergoing immunotherapy.
December 12, 2024
PET/CT images of F-18 AlF-NOTA-BCP137 in patients with hepatocellular carcinoma (HCC) and immunofluorescence analysis of patient tissues. (A) F-18 AlF-NOTA-BCP137 PET/CT images before and after immunotherapy for patient 1 and patient 2. (B) F-18 AlF-NOTA-BCP137 PET/CT and MR images of patient 3 (left panels) after one cycle of immunotherapy. PET images showed higher uptake by tumor and spleen, and PET result was evaluated as positive; therefore, the patient was considered to be responder to treatment and underwent surgical resection. Representative images of hematoxylin and eosin (HE) staining and multiplex immunofluorescence of CD8 and CD137 (right panels) in HCC tumor and adjacent normal tissues of patient 3 after surgery. Nuclei were stained with 4′,6-diamidino-2-phenylindole. Primary tumors are indicated by white arrows, and increased thyroid uptake is indicated by red arrow in PET images. Image courtesy of the Journal of Nuclear Medicine.
Interventional
Shutting down angio systems reduces environmental impact
Shutting down angiography imaging systems after 15 minutes of idle time has the potential to save nearly half of the system’s annual energy consumption.
December 9, 2024
Planet2
Molecular Imaging
New SPECT-based coronary risk score developed for women
A new risk score based on SPECT imaging and other variables can accurately predict risks for women of major adverse cardiovascular events.
December 6, 2024
Heart Infection
Molecular Imaging
AI chatbots tested on patient questions about Lu-177 PSMA-617
AI chatbots have considerable potential to answer common patient questions about theranostics treatments but struggle with the complexity of the topic.
December 5, 2024
Chatgpthead
RSNA 2024
AI x-ray tool improves screening for osteoporosis
A commercially available AI model helped identify patients at risk of low bone mineral density in a real clinical setting.
December 4, 2024
Ai Showcase
Page 1 of 42
Next Page
Top Stories
Top 10 Gold Social
Clinical News
Body composition analysis, MRI safety topped 2024's most read articles
While COVID and radiology salaries hit the top of AuntMinnie.com's Top 10 most-read posts of 2023, they rounded out the bottom of this year's list.
Neiman Hpi
Practice Management
Neiman index outperforms Charlson for predicting imaging use
Mammogram Patient
Womens Imaging
40% of women in their 40s forgo biennial breast cancer screening
Corporate Transparency
Risk Management
Practices must comply with the Corporate Transparency Act
Kidneys
Nuclear Medicine
Kidneys appear to tolerate Lu-177 treatments
More in Home
Body composition analysis, MRI safety topped 2024's most read articles
By Liz Carey
While COVID and radiology salaries hit the top of AuntMinnie.com's Top 10 most-read posts of 2023, they rounded out the bottom of this year's list.
December 20, 2024
Top 10 Gold Social
Neiman index outperforms Charlson for predicting imaging use
By Kate Madden Yee
The Neiman Imaging Comorbidity Index outperforms the Charlson Comorbidity Index for predicting advanced imaging use.
December 20, 2024
Neiman Hpi
40% of women in their 40s forgo biennial breast cancer screening
By Amerigo Allegretto
About two in every five women in their 40s do not undergo biennial breast cancer screening per USPSTF recommendations.
December 20, 2024
Mammogram Patient
Practices must comply with the Corporate Transparency Act
By Healthcare Administrative Partners
A new column from Healthcare Administrative Partners discusses the impact of the Corporate Transparency Act on medical practices.
December 20, 2024
Corporate Transparency
Kidneys appear to tolerate Lu-177 treatments
By Will Morton
Kidney-absorbed doses of lutetium-177 (Lu-177)-based treatments for prostate cancer and neuroendocrine tumors appear to be below toxicity thresholds.
December 19, 2024
Kidneys
Higher Medicaid-to-Medicare reimbursement ratios boost imaging use
By Kate Madden Yee
Higher Medicaid-to-Medicare reimbursement ratios are linked to increased likelihood of Medicaid patients receiving CT, MR, ultrasound, and x-ray imaging.
December 19, 2024
Money Hundred Bills
AI algorithm 'harmonizes' brain MRI data from different scanners
By Kate Madden Yee
A novel machine-learning algorithm used with MRI can harmonize brain volumetric data of patients undergoing Alzheimer's disease assessment gathered from different scanners.
December 18, 2024
Mri Brain Head
Recommendations address AI bias, data transparency
By Amerigo Allegretto
New recommendations seek to make medical AI safe and effective for everyone by tackling the issues of bias and transparency.
December 18, 2024
Artificial Intelligence Ai Suit
AdvaMed applauds House Task Force on AI report
By AuntMinnie.com staff writers
AdvaMed commended the end-of-year report submitted to the U.S. Congress on December 17 by the House Task Force on AI.
December 18, 2024
Artificial Intelligence Ai Abstract 400
African American men respond more favorably to Ra-223 therapy
By Will Morton
African American men with metastatic castrate-resistant prostate cancer may respond more favorably than white men to treatment with radium-223.
December 17, 2024
Prostate Imaging
What radiology trainees should know heading into 2025
By Liz Carey
Radiologists discuss specialty and job market: 10 takeaways.
December 17, 2024
Radiology Practice Models 2024
Solis acquires San Antonio, TX imaging centers
By AuntMinnie.com staff writers
Solis Mammography has acquired Avestēe Women's Imaging Centers in San Antonio, TX.
December 16, 2024
Breast Screening Mammo
Page 1 of 107
Next Page